Randomized Controlled Trial
Abbreviation: RCT
Definition
The gold standard clinical study design in which participants are randomly assigned to receive either the investigational treatment or a control (such as placebo), enabling researchers to establish causal relationships between the intervention and observed outcomes.
Randomized Controlled Trial
A randomized controlled trial (RCT) is a type of clinical study in which participants are allocated to different treatment groups through a random process, such as computer-generated randomization sequences. This random assignment ensures that known and unknown confounding factors are evenly distributed across groups, allowing any observed differences in outcomes to be attributed to the treatment itself rather than to baseline differences between participants. RCTs are universally regarded as the highest level of evidence for evaluating the efficacy and safety of medical interventions and are required by regulatory agencies such as the FDA for drug approval.
In the development of retatrutide, RCTs have been central to establishing the drug’s clinical profile. The Phase 2 trial was a randomized, double-blind, placebo-controlled study in which participants with obesity or overweight were randomly assigned to receive one of several retatrutide dose levels or placebo. This design allowed investigators to quantify the dose-response relationship for weight loss and glycemic improvement while controlling for non-pharmacological factors such as lifestyle changes, the placebo effect, and natural disease variability.
The integrity of an RCT depends on several key design elements: adequate sample size to detect meaningful treatment differences, appropriate randomization to prevent selection bias, blinding to minimize assessment bias, and pre-specified endpoints to avoid data-driven conclusions. When these elements are properly implemented, RCTs provide the most reliable evidence for clinical decision-making and regulatory review, forming the foundation upon which new therapies like retatrutide ultimately gain approval for widespread clinical use.